SkyAI, Inc.

SkyAI, Inc. (STSS) priced its initial public offering on Apr 15, 2022 at $4.25 per share, raising $15.9M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $39M. Aegis Capital was lead-left underwriter. Sichenzia Ross Ference Carmel advised the company and Kaufman & Canoles advised the underwriters.

At its 2022 IPO, Sharps Technology, Inc. (now SkyAI, Inc.) was a medical device company that designed and patented safety syringes, branded Sharps Provensa, which are ultra-low waste with passive safety features. The FDA-cleared products were still being commercialized.

Status

IPO

Ticker

STSS

Exchange

Nasdaq Capital Market

Priced

Apr 15, 2022

IPO price

$4.25

Raised

$15.9M

Market cap at IPO price

$39M

First filed

Mar 18, 2022

Underwriters

Aegis Capital

Company counsel

Sichenzia Ross Ference Carmel

Underwriters' counsel

Kaufman & Canoles

Sector

Financials

Country / state

NY

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.